Moreover, Xue et al. pointed out the importance of the guanylate cyclase-cyclic guanosine monophosphate-protein kinase G (GC-cGMP-PKG) pathway, which mediated the potency of empagliflozin to alleviate diabetes-induced oxidative injury, apoptosis and pyroptosis [89]. Here, GC is linked to diabetes mellitus.